Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers


  Free Subscription

Articles published in PLoS One

Retrieve available abstracts of 111 articles:
HTML format

Single Articles

    January 2021
  1. BARLASS U, Deshmukh A, Beck T, Bishehsari F, et al
    Opioid use as a potential risk factor for pancreatic cancer in the United States: An analysis of state and national level databases.
    PLoS One. 2021;16:e0244285.
    PubMed     Abstract available

  2. YOSHIOKA R, Imamura H, Ichida H, Gyoda Y, et al
    Simulation training in pancreatico-jejunostomy using an inanimate biotissue model improves the technical skills of hepatobiliary-pancreatic surgical fellows.
    PLoS One. 2021;16:e0244915.
    PubMed     Abstract available

  3. YABE SG, Fukuda S, Nishida J, Takeda F, et al
    Efficient induction of pancreatic alpha cells from human induced pluripotent stem cells by controlling the timing for BMP antagonism and activation of retinoic acid signaling.
    PLoS One. 2021;16:e0245204.
    PubMed     Abstract available

  4. CHENG K, Liu W, You J, Shah S, et al
    Safety of laparoscopic pancreaticoduodenectomy in patients with liver cirrhosis using propensity score matching.
    PLoS One. 2021;16:e0246364.
    PubMed     Abstract available

  5. XIE J, Peng Y, Chen X, Li Q, et al
    LACTB mRNA expression is increased in pancreatic adenocarcinoma and high expression indicates a poor prognosis.
    PLoS One. 2021;16:e0245908.
    PubMed     Abstract available

  6. HOLLENBACH M, Sonnenberg S, Sommerer I, Lorenz J, et al
    Pitfalls in AR42J-model of cerulein-induced acute pancreatitis.
    PLoS One. 2021;16:e0242706.
    PubMed     Abstract available

  7. SOGAWA K, Takano S, Ishige T, Yoshitomi H, et al
    Usefulness of the MALDI-TOF MS technology with membrane filter protocol for the rapid identification of microorganisms in perioperative drainage fluids of hepatobiliary pancreatic surgery.
    PLoS One. 2021;16:e0246002.
    PubMed     Abstract available

  8. MUTHULINGAM JA, Olesen SS, Hansen TM, Brock C, et al
    Cervical transcutaneous vagal neuromodulation in chronic pancreatitis patients with chronic pain: A randomised sham controlled clinical trial.
    PLoS One. 2021;16:e0247653.
    PubMed     Abstract available

  9. LI T, Zhao H, Zhou H, Geng T, et al
    LncRNA LINC00857 strengthens the malignancy behaviors of pancreatic adenocarcinoma cells by serving as a competing endogenous RNA for miR-340-5p to upregulate TGFA expression.
    PLoS One. 2021;16:e0247817.
    PubMed     Abstract available

  10. ZHANG C, Huang L, Xiong J, Xie L, et al
    Isoalantolactone inhibits pancreatic cancer proliferation by regulation of PI3K and Wnt signal pathway.
    PLoS One. 2021;16:e0247752.
    PubMed     Abstract available

  11. CAO H, Qiang L, Chen J, Johnson KM, et al
    Synergistic metalloproteinase-based remodeling of matrix by pancreatic tumor and stromal cells.
    PLoS One. 2021;16:e0248111.
    PubMed     Abstract available

  12. WEYHE D, Obonyo D, Uslar VN, Stricker I, et al
    Predictive factors for long-term survival after surgery for pancreatic ductal adenocarcinoma: Making a case for standardized reporting of the resection margin using certified cancer center data.
    PLoS One. 2021;16:e0248633.
    PubMed     Abstract available

  13. CHENG YH, Chiang EI, Syu JN, Chao CY, et al
    Treatment of 13-cis retinoic acid and 1,25-dihydroxyvitamin D3 inhibits TNF-alpha-mediated expression of MMP-9 protein and cell invasion through the suppression of JNK pathway and microRNA 221 in human pancreatic adenocarcinoma cancer cells.
    PLoS One. 2021;16:e0247550.
    PubMed     Abstract available

  14. SUGAWARA T, Ban D, Nishino J, Watanabe S, et al
    Prediction of early recurrence of pancreatic ductal adenocarcinoma after resection.
    PLoS One. 2021;16:e0249885.
    PubMed     Abstract available

  15. ZHANG W, Sakoda H, Nakazato Y, Islam MN, et al
    Neuromedin U uses Galphai2 and Galphao to suppress glucose-stimulated Ca2+ signaling and insulin secretion in pancreatic beta cells.
    PLoS One. 2021;16:e0250232.
    PubMed     Abstract available

  16. ZHONG R, Jiang X, Peng Y, Xu H, et al
    A nomogram prediction of overall survival based on lymph node ratio, AJCC 8th staging system, and other factors for primary pancreatic cancer.
    PLoS One. 2021;16:e0249911.
    PubMed     Abstract available

  17. TARTAGLIONE S, Mancini P, Viggiani V, Chirletti P, et al
    PIVKA-II: A biomarker for diagnosing and monitoring patients with pancreatic adenocarcinoma.
    PLoS One. 2021;16:e0251656.
    PubMed     Abstract available

  18. TIAN T, Yang Q, Zhang C, Li X, et al
    MiRNA-107 enhances the malignant progression of pancreatic cancer by targeting TGFBR3.
    PLoS One. 2021;16:e0249375.
    PubMed     Abstract available

  19. ANTWI K, Wiesner P, Merkle EM, Zech CJ, et al
    Investigating difficult to detect pancreatic lesions: Characterization of benign pancreatic islet cell tumors using multiparametric pancreatic 3-T MRI.
    PLoS One. 2021;16:e0253078.
    PubMed     Abstract available

  20. KATO T, Ono H, Fujii M, Akahoshi K, et al
    Cytoplasmic RRM1 activation as an acute response to gemcitabine treatment is involved in drug resistance of pancreatic cancer cells.
    PLoS One. 2021;16:e0252917.
    PubMed     Abstract available

  21. DHAYAT SA, Tamim ANJ, Jacob M, Ebeling G, et al
    Postoperative pancreatic fistula affects recurrence-free survival of pancreatic cancer patients.
    PLoS One. 2021;16:e0252727.
    PubMed     Abstract available

  22. MALHOTRA A, Rachet B, Bonaventure A, Pereira SP, et al
    Can we screen for pancreatic cancer? Identifying a sub-population of patients at high risk of subsequent diagnosis using machine learning techniques applied to primary care data.
    PLoS One. 2021;16:e0251876.
    PubMed     Abstract available

  23. RAJA A, Malik MFA, Haq F
    Genomic relevance of FGF14 and associated genes on the prognosis of pancreatic cancer.
    PLoS One. 2021;16:e0252344.
    PubMed     Abstract available

  24. PEISL S, Mellenthin C, Vignot L, Gonelle-Gispert C, et al
    Therapeutic targeting of STAT3 pathways in pancreatic adenocarcinoma: A systematic review of clinical and preclinical literature.
    PLoS One. 2021;16:e0252397.
    PubMed     Abstract available

  25. UDRISTOIU AL, Cazacu IM, Gruionu LG, Gruionu G, et al
    Real-time computer-aided diagnosis of focal pancreatic masses from endoscopic ultrasound imaging based on a hybrid convolutional and long short-term memory neural network model.
    PLoS One. 2021;16:e0251701.
    PubMed     Abstract available

  26. ULLGREN H, Fransson P, Olofsson A, Segersvard R, et al
    Health care utilization at end of life among patients with lung or pancreatic cancer. Comparison between two Swedish cohorts.
    PLoS One. 2021;16:e0254673.
    PubMed     Abstract available

  27. ITO G, Kawakami K, Aoyama T, Yokokawa T, et al
    Risk factors for severe neutropenia in pancreatic cancer patients treated with gemcitabine/nab-paclitaxel combination therapy.
    PLoS One. 2021;16:e0254726.
    PubMed     Abstract available

  28. STREICHER SA, Lim U, Park SL, Li Y, et al
    Genome-wide association study of pancreatic fat: The Multiethnic Cohort Adiposity Phenotype Study.
    PLoS One. 2021;16:e0249615.
    PubMed     Abstract available

  29. IMURA T, Inagaki A, Igarashi Y, Goto M, et al
    Optimization of dye solutions for detecting damaged pancreatic tissues during islet isolation procedures.
    PLoS One. 2021;16:e0255733.
    PubMed     Abstract available

  30. KAFITA D, Nkhoma P, Zulu M, Sinkala M, et al
    Proteogenomic analysis of pancreatic cancer subtypes.
    PLoS One. 2021;16:e0257084.
    PubMed     Abstract available

  31. BARKO PC, Williams DA
    Untargeted analysis of the serum metabolome in cats with exocrine pancreatic insufficiency.
    PLoS One. 2021;16:e0257856.
    PubMed     Abstract available

  32. GAO Y, Wang M, Guo X, Hu J, et al
    Renalase is a novel tissue and serological biomarker in pancreatic ductal adenocarcinoma.
    PLoS One. 2021;16:e0250539.
    PubMed     Abstract available

  33. WESTENFELDER C, Hu Z, Zhang P, Gooch A, et al
    Intraperitoneal administration of human "Neo-Islets", 3-D organoids of mesenchymal stromal and pancreatic islet cells, normalizes blood glucose levels in streptozotocin-diabetic NOD/SCID mice: Significance for clinical trials.
    PLoS One. 2021;16:e0259043.
    PubMed     Abstract available

  34. WAKIYA T, Ishido K, Kimura N, Nagase H, et al
    Prediction of massive bleeding in pancreatic surgery based on preoperative patient characteristics using a decision tree.
    PLoS One. 2021;16:e0259682.
    PubMed     Abstract available

  35. MAEDA K, Kuriyama N, Nakagawa Y, Ito T, et al
    Optimal management of peripancreatic fluid collection with postoperative pancreatic fistula after distal pancreatectomy: Significance of computed tomography values for predicting fluid infection.
    PLoS One. 2021;16:e0259701.
    PubMed     Abstract available

  36. XU YF, Xu X, Bhandari K, Gin A, et al
    Isolation of extra-cellular vesicles in the context of pancreatic adenocarcinomas: Addition of one stringent filtration step improves recovery of specific microRNAs.
    PLoS One. 2021;16:e0259563.
    PubMed     Abstract available

  37. JANG DK, Ahn DW, Lee KL, Kim BG, et al
    Impacts of body composition parameters and liver cirrhosis on the severity of alcoholic acute pancreatitis.
    PLoS One. 2021;16:e0260309.
    PubMed     Abstract available

  38. LI X, Yang Q, Ye H, Li S, et al
    Comparison of pancreatic fat content measured by different methods employing MR mDixon sequence.
    PLoS One. 2021;16:e0260001.
    PubMed     Abstract available

  39. PULIPATI VP, Amblee A, Yap SET, Shaka H, et al
    Hypertriglyceridemia-associated acute pancreatitis: Response to continuous insulin infusion.
    PLoS One. 2021;16:e0260495.
    PubMed     Abstract available

    January 2020
  40. OHKUMA R, Yada E, Ishikawa S, Komura D, et al
    High expression of olfactomedin-4 is correlated with chemoresistance and poor prognosis in pancreatic cancer.
    PLoS One. 2020;15:e0226707.
    PubMed     Abstract available

  41. PLAYFORD RJ, Marchbank T
    Pancreatic secretory trypsin inhibitor reduces multi-organ injury caused by gut ischemia/reperfusion in mice.
    PLoS One. 2020;15:e0227059.
    PubMed     Abstract available

  42. BROWN M, Zhang W, Yan D, Kenath R, et al
    The role of survivin in the progression of pancreatic ductal adenocarcinoma (PDAC) and a novel survivin-targeted therapeutic for PDAC.
    PLoS One. 2020;15:e0226917.
    PubMed     Abstract available

  43. ANDO Y, Ohuchida K, Otsubo Y, Kibe S, et al
    Necroptosis in pancreatic cancer promotes cancer cell migration and invasion by release of CXCL5.
    PLoS One. 2020;15:e0228015.
    PubMed     Abstract available

  44. SINGH S, McDonald JT, Ilie G, Adisesh A, et al
    An examination of the association between lifetime history of prostate and pancreatic cancer diagnosis and occupation in a population sample of Canadians.
    PLoS One. 2020;15:e0227622.
    PubMed     Abstract available

  45. KHILJI MS, Verstappen D, Dahlby T, Burstein Prause MC, et al
    The intermediate proteasome is constitutively expressed in pancreatic beta cells and upregulated by stimulatory, low concentrations of interleukin 1 beta.
    PLoS One. 2020;15:e0222432.
    PubMed     Abstract available

  46. Expression of Concern: Reduction in ATP Levels Triggers Immunoproteasome Activation by the 11S (PA28) Regulator during Early Antiviral Response Mediated by IFNbeta in Mouse Pancreatic beta-Cells.
    PLoS One. 2020;15:e0229516.

  47. SOLANKI A, King D, Thibault G, Wang L, et al
    Quantification of fluorophore distribution and therapeutic response in matched in vivo and ex vivo pancreatic cancer model systems.
    PLoS One. 2020;15:e0229407.
    PubMed     Abstract available

  48. USON PLS JUNIOR, Tolentino FDS, Santos VM, Rother ET, et al
    The impact of metastatic sites in advanced pancreatic adenocarcinoma, systematic review and meta-analysis of prospective randomized studies.
    PLoS One. 2020;15:e0230060.
    PubMed     Abstract available

  49. WOLFE D, Kanji S, Yazdi F, Barbeau P, et al
    Drug induced pancreatitis: A systematic review of case reports to determine potential drug associations.
    PLoS One. 2020;15:e0231883.
    PubMed     Abstract available

  50. FANCHON LM, Russell J, Pillarsetty N, O'Donoghue I, et al
    Comparing the intra-tumoral distribution of Gemcitabine, 5-Fluorouracil, and Capecitabine in a murine model of pancreatic ductal adenocarcinoma.
    PLoS One. 2020;15:e0231745.
    PubMed     Abstract available

  51. BUSTOS AS, Hakansson A, Linares-Pasten JA, Penarrieta JM, et al
    Interaction of quercetin and epigallocatechin gallate (EGCG) aggregates with pancreatic lipase under simplified intestinal conditions.
    PLoS One. 2020;15:e0224853.
    PubMed     Abstract available

  52. DEMIRKOL CANLI S, Dedeoglu E, Akbar MW, Kucukkaraduman B, et al
    A novel 20-gene prognostic score in pancreatic adenocarcinoma.
    PLoS One. 2020;15:e0231835.
    PubMed     Abstract available

  53. CHOW JPH, Cai Y, Chow DTL, Chung SHK, et al
    A modified arginine-depleting enzyme NEI-01 inhibits growth of pancreatic cancer cells.
    PLoS One. 2020;15:e0231633.
    PubMed     Abstract available

  54. LUO S, Lenon GB, Gill H, Hung A, et al
    Inhibitory effect of a weight-loss Chinese herbal formula RCM-107 on pancreatic alpha-amylase activity: Enzymatic and in silico approaches.
    PLoS One. 2020;15:e0231815.
    PubMed     Abstract available

  55. TAKENAGA K, Akimoto M, Koshikawa N, Nagase H, et al
    Cancer cell-derived interleukin-33 decoy receptor sST2 enhances orthotopic tumor growth in a murine pancreatic cancer model.
    PLoS One. 2020;15:e0232230.
    PubMed     Abstract available

  56. Retraction: Concomitant Targeting of EGF Receptor, TGF-beta and Src Points to a Novel Therapeutic Approach in Pancreatic Cancer.
    PLoS One. 2020;15:e0233436.

  57. Expression of Concern: DUSP1 Is a Novel Target for Enhancing Pancreatic Cancer Cell Sensitivity to Gemcitabine.
    PLoS One. 2020;15:e0233098.

  58. LAI HC, Lee MS, Liu YT, Lin KT, et al
    Propofol-based intravenous anesthesia is associated with better survival than desflurane anesthesia in pancreatic cancer surgery.
    PLoS One. 2020;15:e0233598.
    PubMed     Abstract available

  59. HARADA N, Nomura M, Yoda Y, Matsumura S, et al
    Food texture affects glucose tolerance by altering pancreatic beta-cell function in mice consuming high-fructose corn syrup.
    PLoS One. 2020;15:e0233797.
    PubMed     Abstract available

  60. CHOU CK, Lee KC, Luo JC, Chen TS, et al
    Endoscopic papillary balloon dilatation less than three minutes for biliary stone removal increases the risk of post-ERCP pancreatitis.
    PLoS One. 2020;15:e0233388.
    PubMed     Abstract available

  61. SHINJO K, Hara K, Nagae G, Umeda T, et al
    A novel sensitive detection method for DNA methylation in circulating free DNA of pancreatic cancer.
    PLoS One. 2020;15:e0233782.
    PubMed     Abstract available

  62. ABU-SHAWER O, Abu-Shawer M, Shurman A, Lattouf A, et al
    The clinical value of peripheral immune cell counts in pancreatic cancer.
    PLoS One. 2020;15:e0232043.
    PubMed     Abstract available

  63. KLAK M, Gomolka M, Dobrzanski T, Tymicki G, et al
    Irradiation with 365 nm and 405 nm wavelength shows differences in DNA damage of swine pancreatic islets.
    PLoS One. 2020;15:e0235052.
    PubMed     Abstract available

  64. UESATO Y, Sasahira N, Ozaka M, Sasaki T, et al
    Evaluation of circulating tumor DNA as a biomarker in pancreatic cancer with liver metastasis.
    PLoS One. 2020;15:e0235623.
    PubMed     Abstract available

  65. SATO K, Hikita H, Myojin Y, Fukumoto K, et al
    Hyperglycemia enhances pancreatic cancer progression accompanied by elevations in phosphorylated STAT3 and MYC levels.
    PLoS One. 2020;15:e0235573.
    PubMed     Abstract available

  66. SHINOURA S, Tokushige A, Chinen K, Mori H, et al
    Endosonographic finding of the simultaneous depiction of bile and pancreatic ducts can predict difficult biliary cannulation on endoscopic retrograde cholangiopancreatography.
    PLoS One. 2020;15:e0235757.
    PubMed     Abstract available

  67. SUZUKI Y, Takadate T, Mizuma M, Shima H, et al
    Stromal expression of hemopexin is associated with lymph-node metastasis in pancreatic ductal adenocarcinoma.
    PLoS One. 2020;15:e0235904.
    PubMed     Abstract available

  68. BOLM L, Zghurskyi P, Lapshyn H, Petrova E, et al
    Alignment of stroma fibers, microvessel density and immune cell populations determine overall survival in pancreatic cancer-An analysis of stromal morphology.
    PLoS One. 2020;15:e0234568.
    PubMed     Abstract available

  69. MOGENSEN PR, Grell K, Schmiegelow K, Overgaard UM, et al
    Dyslipidemia at diagnosis of childhood acute lymphoblastic leukemia.
    PLoS One. 2020;15:e0231209.
    PubMed     Abstract available

  70. MIYAKE H, Sakagami J, Yasuda H, Sogame Y, et al
    Correction: Association of fatty pancreas with pancreatic endocrine and exocrine function.
    PLoS One. 2020;15:e0236915.
    PubMed     Abstract available

  71. TAKAHASHI M, Shibasaki M, Echizen H, Kushiyama A, et al
    Comparisons between dipeptidyl peptidase-4 inhibitors and other classes of hypoglycemic drugs using two distinct biomarkers of pancreatic beta-cell function: A meta-analysis.
    PLoS One. 2020;15:e0236603.
    PubMed     Abstract available

  72. HAL WA, Straza MW, Chen X, Mickevicius N, et al
    Initial clinical experience of Stereotactic Body Radiation Therapy (SBRT) for liver metastases, primary liver malignancy, and pancreatic cancer with 4D-MRI based online adaptation and real-time MRI monitoring using a 1.5 Tesla MR-Linac.
    PLoS One. 2020;15:e0236570.
    PubMed     Abstract available

  73. XIE F, Chen Q, Zhou Y, Chen W, et al
    Characterization of patients with advanced chronic pancreatitis using natural language processing of radiology reports.
    PLoS One. 2020;15:e0236817.
    PubMed     Abstract available

  74. UHLEMEYER C, Muller N, Griess K, Wessel C, et al
    ATM and P53 differentially regulate pancreatic beta cell survival in Ins1E cells.
    PLoS One. 2020;15:e0237669.
    PubMed     Abstract available

  75. BERNARD B, Rajamanickam V, Dubay C, Piening B, et al
    Transcriptional and immunohistological assessment of immune infiltration in pancreatic cancer.
    PLoS One. 2020;15:e0238380.
    PubMed     Abstract available

  76. LEE J, Lee JC, Kim HW, Kim J, et al
    Postoperative muscle mass restoration as a prognostic factor in patients with resected pancreatic cancer.
    PLoS One. 2020;15:e0238649.
    PubMed     Abstract available

  77. MARGARYAN S, Kriegova E, Fillerova R, Smotkova Kraiczova V, et al
    Hypomethylation of IL1RN and NFKB1 genes is linked to the dysbalance in IL1beta/IL-1Ra axis in female patients with type 2 diabetes mellitus.
    PLoS One. 2020;15:e0233737.
    PubMed     Abstract available

  78. BOAS FE, Nurili F, Bendet A, Cheleuitte-Nieves C, et al
    Induction and characterization of pancreatic cancer in a transgenic pig model.
    PLoS One. 2020;15:e0239391.
    PubMed     Abstract available

  79. CHOI MH, Yoon SB, Song M, Lee IS, et al
    Benefits of the multiplanar and volumetric analyses of pancreatic cancer using computed tomography.
    PLoS One. 2020;15:e0240318.
    PubMed     Abstract available

  80. NWEKE EE, Naicker P, Aron S, Stoychev S, et al
    SWATH-MS based proteomic profiling of pancreatic ductal adenocarcinoma tumours reveals the interplay between the extracellular matrix and related intracellular pathways.
    PLoS One. 2020;15:e0240453.
    PubMed     Abstract available

  81. YAMAMOTO S, Nagamine Y, Miyashita T, Ito S, et al
    Perioperative and anesthetic risk factors of surgical site infection in patients undergoing pancreaticoduodenectomy: A retrospective cohort study.
    PLoS One. 2020;15:e0240490.
    PubMed     Abstract available

  82. PAVLIKOVA N, Sramek J, Jelinek M, Halada P, et al
    Markers of acute toxicity of DDT exposure in pancreatic beta-cells determined by a proteomic approach.
    PLoS One. 2020;15:e0229430.
    PubMed     Abstract available

  83. CEBALLOS GA, Hernandez LF, Paredes D, Betancourt LR, et al
    A machine learning approach to predict pancreatic islet grafts rejection versus tolerance.
    PLoS One. 2020;15:e0241925.
    PubMed     Abstract available

  84. Correction: Initial clinical experience of Stereotactic Body Radiation Therapy (SBRT) for liver metastases, primary liver malignancy, and pancreatic cancer with 4D-MRI based online adaptation and real-time MRI monitoring using a 1.5 Tesla MR-Linac.
    PLoS One. 2020;15:e0242146.
    PubMed     Abstract available

  85. HUNG WC, Lee DY, Chiang EI, Syu JN, et al
    Docosahexaenoic acid inhibits the proliferation of Kras/TP53 double mutant pancreatic ductal adenocarcinoma cells through modulation of glutathione level and suppression of nucleotide synthesis.
    PLoS One. 2020;15:e0241186.
    PubMed     Abstract available

  86. THAKAR M, Hu Y, Morreale M, Lerner L, et al
    Correction: A novel epigenetic modulating agent sensitizes pancreatic cells to a chemotherapy agent.
    PLoS One. 2020;15:e0242974.
    PubMed     Abstract available

  87. SHEIKH M, Masoudi S, Bakhshandeh R, Moayyedkazemi A, et al
    Survival features, prognostic factors, and determinants of diagnosis and treatment among Iranian patients with pancreatic cancer, a prospective study.
    PLoS One. 2020;15:e0243511.
    PubMed     Abstract available

  88. ROH YH, Kang BK, Song SY, Lee CM, et al
    Preoperative CT anthropometric measurements and pancreatic pathology increase risk for postoperative pancreatic fistula in patients following pancreaticoduodenectomy.
    PLoS One. 2020;15:e0243515.
    PubMed     Abstract available

  89. WOCHNER R, Clauss D, Nattenmuller J, Tjaden C, et al
    Impact of progressive resistance training on CT quantified muscle and adipose tissue compartments in pancreatic cancer patients.
    PLoS One. 2020;15:e0242785.
    PubMed     Abstract available

  90. DOI N, Ino Y, Angata K, Shimada K, et al
    Clinicopathological significance of core 3 O-glycan synthetic enzyme, beta1,3-N-acetylglucosaminyltransferase 6 in pancreatic ductal adenocarcinoma.
    PLoS One. 2020;15:e0242851.
    PubMed     Abstract available

  91. GASTEIGER S, Primavesi F, Werkl P, Dostal L, et al
    The prognostic value of Presepsin for postoperative complications following pancreatic resection: A prospective study.
    PLoS One. 2020;15:e0243510.
    PubMed     Abstract available

  92. DUORUI N, Shi B, Zhang T, Chen C, et al
    The contemporary trend in worsening prognosis of pancreatic acinar cell carcinoma: A population-based study.
    PLoS One. 2020;15:e0243164.
    PubMed     Abstract available

  93. MAHARAJ AD, Evans SM, Zalcberg JR, Ioannou LJ, et al
    Barriers and enablers to the implementation of protocol-based imaging in pancreatic cancer: A qualitative study using the theoretical domains framework.
    PLoS One. 2020;15:e0243312.
    PubMed     Abstract available

  94. LIN ZB, Song JY, Li AC, Chen C, et al
    The benefit of adjuvant radiotherapy on overall survival in resected stage I to II pancreatic cancer: A propensity-adjusted analysis.
    PLoS One. 2020;15:e0243170.
    PubMed     Abstract available

  95. RAJPUT SA, Mirza MR, Choudhary MI
    Bergenin protects pancreatic beta cells against cytokine-induced apoptosis in INS-1E cells.
    PLoS One. 2020;15:e0241349.
    PubMed     Abstract available

  96. GRUBER ES, Jomrich G, Tamandl D, Gnant M, et al
    Correction: Sarcopenia and sarcopenic obesity are independent adverse prognostic factors in resectable pancreatic ductal adenocarcinoma.
    PLoS One. 2020;15:e0244896.
    PubMed     Abstract available

  97. CHEN CY, Liang SH, Su YY, Chiang NJ, et al
    Modified gemcitabine, S-1, and leucovorin combination for patients with newly diagnosed locally advanced or metastatic pancreatic adenocarcinoma: A multi-center retrospective study in Taiwan.
    PLoS One. 2020;15:e0244487.
    PubMed     Abstract available

    January 2019
  98. KAISSIS G, Ziegelmayer S, Lohofer F, Steiger K, et al
    A machine learning algorithm predicts molecular subtypes in pancreatic ductal adenocarcinoma with differential response to gemcitabine-based versus FOLFIRINOX chemotherapy.
    PLoS One. 2019;14:e0218642.
    PubMed     Abstract available

  99. KELLAWAY SG, Mosinska K, Mohamed Z, Ryan A, et al
    Correction: Increased proliferation and altered cell cycle regulation in pancreatic stem cells derived from patients with congenital hyperinsulinism.
    PLoS One. 2019;14:e0223999.
    PubMed     Abstract available

  100. SANKAR KS, Altamentova SM, Rocheleau JV
    Hypoxia induction in cultured pancreatic islets enhances endothelial cell morphology and survival while maintaining beta-cell function.
    PLoS One. 2019;14:e0222424.
    PubMed     Abstract available

  101. AIER I, Semwal R, Dhara A, Sen N, et al
    An integrated epigenome and transcriptome analysis identifies PAX2 as a master regulator of drug resistance in high grade pancreatic ductal adenocarcinoma.
    PLoS One. 2019;14:e0223554.
    PubMed     Abstract available

  102. KOBAYASHI M, Ryozawa S, Iwano H, Araki R, et al
    The usefulness of wire-guided endoscopic snare papillectomy for tumors of the major duodenal papilla.
    PLoS One. 2019;14:e0211019.
    PubMed     Abstract available

  103. KAUNE T, Hollenbach M, Keil B, Chen JM, et al
    Common variants in glyoxalase I do not increase chronic pancreatitis risk.
    PLoS One. 2019;14:e0222927.
    PubMed     Abstract available

  104. Expression of Concern: Cooperativity of Oncogenic K-Ras and Downregulated p16/INK4A in Human Pancreatic Tumorigenesis.
    PLoS One. 2019;14:e0225279.

  105. JANG E, Son M, Jang J, Lee IH, et al
    DHP23002 as a next generation oral paclitaxel formulation for pancreatic cancer therapy.
    PLoS One. 2019;14:e0225095.
    PubMed     Abstract available

  106. KATO S, Iwasaki A, Kurita Y, Arimoto J, et al
    Three-dimensional analysis of pancreatic fat by fat-water magnetic resonance imaging provides detailed characterization of pancreatic steatosis with improved reproducibility.
    PLoS One. 2019;14:e0224921.
    PubMed     Abstract available

  107. KUBO K, Wadasaki K, Komichi D, Sasaki T, et al
    A single institution experience of the treatment of pancreatic ductal carcinoma: The demand and the role of radiation therapy.
    PLoS One. 2019;14:e0227305.
    PubMed     Abstract available

  108. PARK D, Shakya R, Koivisto C, Pitarresi JR, et al
    Murine models for familial pancreatic cancer: Histopathology, latency and drug sensitivity among cancers of Palb2, Brca1 and Brca2 mutant mouse strains.
    PLoS One. 2019;14:e0226714.
    PubMed     Abstract available

  109. ALNAHDI A, John A, Raza H
    N-acetyl cysteine attenuates oxidative stress and glutathione-dependent redox imbalance caused by high glucose/high palmitic acid treatment in pancreatic Rin-5F cells.
    PLoS One. 2019;14:e0226696.
    PubMed     Abstract available

  110. ZHENG Z, Wang M, Tan C, Chen Y, et al
    Disparities in survival by stage after surgery between pancreatic head and body/tail in patients with nonmetastatic pancreatic cancer.
    PLoS One. 2019;14:e0226726.
    PubMed     Abstract available

  111. WATANABE F, Suzuki K, Tamaki S, Abe I, et al
    Longitudinal monitoring of KRAS-mutated circulating tumor DNA enables the prediction of prognosis and therapeutic responses in patients with pancreatic cancer.
    PLoS One. 2019;14:e0227366.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Pancreatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.